首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   419473篇
  免费   19140篇
  国内免费   1129篇
耳鼻咽喉   3881篇
儿科学   12981篇
妇产科学   7469篇
基础医学   48679篇
口腔科学   6085篇
临床医学   37009篇
内科学   82907篇
皮肤病学   4043篇
神经病学   39890篇
特种医学   16999篇
外国民族医学   11篇
外科学   66054篇
综合类   5743篇
一般理论   319篇
预防医学   38597篇
眼科学   9219篇
药学   26070篇
  6篇
中国医学   984篇
肿瘤学   32796篇
  2023年   1363篇
  2022年   2414篇
  2021年   5457篇
  2020年   3274篇
  2019年   5325篇
  2018年   27037篇
  2017年   21175篇
  2016年   23652篇
  2015年   6695篇
  2014年   9330篇
  2013年   12516篇
  2012年   24645篇
  2011年   39059篇
  2010年   28476篇
  2009年   20506篇
  2008年   35224篇
  2007年   38236篇
  2006年   17751篇
  2005年   19276篇
  2004年   19387篇
  2003年   19176篇
  2002年   16408篇
  2001年   2353篇
  2000年   1985篇
  1999年   2470篇
  1998年   3253篇
  1997年   2750篇
  1996年   2267篇
  1995年   2186篇
  1994年   1842篇
  1993年   1628篇
  1992年   1297篇
  1991年   1236篇
  1990年   1120篇
  1989年   1063篇
  1988年   1020篇
  1987年   984篇
  1986年   974篇
  1985年   994篇
  1984年   1241篇
  1983年   1145篇
  1982年   1390篇
  1981年   1313篇
  1980年   1186篇
  1979年   708篇
  1978年   755篇
  1977年   638篇
  1976年   593篇
  1975年   474篇
  1974年   492篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
Academic output is just one aspect of a successful career as a plastic surgeon. However, for those with a strong interest in academia, the academic output of a department will likely be a key factor when deciding how to rank jobs. The aim of this study was to quantify and rank the academic output of plastic surgery units across the UK and Ireland. The Institute for Scientific Information (ISI) Web of Science Bibliometric analysis tool was used to collate cumulative (1950–2016), 10 year (2006–2016) and 3 years (2013–2015) research output data for plastic surgery units in the UK and Ireland. Sixty-six plastic surgery units were identified. Departments were ranked for each time period according to the number of papers produced, number of citations (Nc) and h-index (a measure of the impact of scientific output). The top 3 departments for number of papers in the last 10 years were The Royal Free Hospital, London (226) Broomfield Hospital, Chelmsford (218), and Morriston Hospital and Swansea (188). The top 3 for h-number were The Royal Free Hospital (21) Wythenshawe Hospital, Manchester (18) and Morriston Hospital (17). Academic output varies across plastic surgery units in the UK and Ireland. A number of departments have consistently maintained high academic outputs across the years and will be of interest to surgeons hoping to pursue a career in academia.  相似文献   
10.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号